Your request to link to rcsb for Retinoic acid receptor gamma


  • 3LBD: ligand-binding domain of the human retinoic acid receptor gamma bound to 9-cis retinoic acid (10.1038/NSB0398-199 )
  • 1FM6: the 2.1 angstrom resolution crystal structure of the heterodimer of the human rxralpha and ppargamma ligand binding domains respectively bound with 9-cis retinoic acid and rosiglitazone and co-activator peptides. (10.1016/S1097-2765(00)80448-7 )
  • 1FM9: the 2.1 angstrom resolution crystal structure of the heterodimer of the human rxralpha and ppargamma ligand binding domains respectively bound with 9-cis retinoic acid and gi262570 and co-activator peptides. (10.1016/S1097-2765(00)80448-7 )
  • 6A60: crystal structure of human fxr/rxr-lbd heterodimer bound to gw4064 and 9cra and src1 (10.1074/JBC.RA118.004652 )
  • 3OAP: crystal structure of human retinoid x receptor alpha-ligand binding domain complex with 9-cis retinoic acid and the coactivator peptide grip-1 (10.1021/BI101288Y )
  • 3UVV: crystal structure of the ligand binding domains of the thyroid receptor:retinoid x receptor complexed with 3,3',5 triiodo-l- thyronine and 9-cis retinoic acid (10.1073/PNAS.1119852109 )
  • 5JI0: ppargamma-rxralpha(s427f) heterodimer in complex with src-1, rosiglitazone, and 9-cis-retanoic acid
  • 1XIU: crystal structure of the agonist-bound ligand-binding domain of biomphalaria glabrata rxr (10.1016/J.JMB.2005.09.090 )
  • 6A5Y: crystal structure of human fxr/rxr-lbd heterodimer bound to hnc143 and 9cra and src1 (10.1074/JBC.RA118.004652 )
  • 6A5Z: crystal structure of human fxr/rxr-lbd heterodimer bound to hnc180 and 9cra and src1 (10.1074/JBC.RA118.004652 )
  • 1EPB: structure of the epididymal retinoic acid-binding protein at 2.1 angstroms resolution (10.1016/0969-2126(93)90004-Z )
  • 5UAN: crystal structure of multi-domain rar-beta-rxr-alpha heterodimer on dna (10.1038/S41467-017-00981-Y )
  • 1XLS: crystal structure of the mouse car/rxr lbd heterodimer bound to tcpobop and 9cra and a tif2 peptide containg the third lxxll motifs (10.1016/J.MOLCEL.2004.11.036 )
  • 3DZU: intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide (10.1038/NATURE07413 )
  • 3DZY: intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide (10.1038/NATURE07413 )
  • 1TYR: transthyretin complex with retinoic acid (10.1111/J.1432-1033.1995.563_B.X )
  • 1XDK: crystal structure of the rarbeta/rxralpha ligand binding domain heterodimer in complex with 9-cis retinoic acid and a fragment of the trap220 coactivator (10.1074/JBC.M409302200 )
  • 2NNH: cyp2c8dh complexed with 2 molecules of 9-cis retinoic acid (10.1074/JBC.M802180200 )
  • 4NQA: crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna (10.1038/NSMB.2778 )
  • 5Z12: a structure of fxr/rxr (10.1074/JBC.RA118.004188 )
  • 1K74: the 2.3 angstrom resolution crystal structure of the heterodimer of the human ppargamma and rxralpha ligand binding domains respectively bound with gw409544 and 9-cis retinoic acid and co-activator peptides. (10.1073/PNAS.241410198 )
  • 3E00: intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide (10.1038/NATURE07413 )
  • 1FBY: crystal structure of the human rxr alpha ligand binding domain bound to 9-cis retinoic acid (10.1093/EMBOJ/19.11.2592 )
  • 5M24: rarg mutant-s371e (10.1371/JOURNAL.PONE.0171043 )